Did you know you can get Impactiviti Daily (Top Pharma News) direct to your Inbox each morning? Just click here to subscribe!
Lots on J&J today – Elimination of the comprehensive care business unit; warnings of allergic reactions to its HIV drug Intelence; FDA finger-wagging for “misleading” advertising of athlete’s foot cream; no further development of once-per-month Risperdal Consta.
BMS‘ RA drug Orencia gets an expanded label.
Talent Management. Employee Assessments. We can help. The Impactiviti Partner Network has what you need. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for information and recommendations!
JUST FOR FUN
Talent. Sometimes these TV shows uncover gems. Check out this guy from X-Factor:
Subscribe to the Impactiviti blog via e-mail
Connect with Steve Woodruff